These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8064097)

  • 1. Estrogen replacement therapy and memory in older women.
    Robinson D; Friedman L; Marcus R; Tinklenberg J; Yesavage J
    J Am Geriatr Soc; 1994 Sep; 42(9):919-22. PubMed ID: 8064097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study.
    Grady D; Yaffe K; Kristof M; Lin F; Richards C; Barrett-Connor E
    Am J Med; 2002 Nov; 113(7):543-8. PubMed ID: 12459399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
    Herrington DM; Reboussin DM; Brosnihan KB; Sharp PC; Shumaker SA; Snyder TE; Furberg CD; Kowalchuk GJ; Stuckey TD; Rogers WJ; Givens DH; Waters D
    N Engl J Med; 2000 Aug; 343(8):522-9. PubMed ID: 10954759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.
    Koh KK; Mincemoyer R; Bui MN; Csako G; Pucino F; Guetta V; Waclawiw M; Cannon RO
    N Engl J Med; 1997 Mar; 336(10):683-90. PubMed ID: 9041098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause.
    Woo J; Lau E; Ho SC; Cheng F; Chan C; Chan AS; Haines CJ; Chan TY; Li M; Sham A
    Menopause; 2003; 10(4):352-61. PubMed ID: 12851519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial.
    Hlatky MA; Boothroyd D; Vittinghoff E; Sharp P; Whooley MA;
    JAMA; 2002 Feb; 287(5):591-7. PubMed ID: 11829697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
    Shlipak MG; Simon JA; Vittinghoff E; Lin F; Barrett-Connor E; Knopp RH; Levy RI; Hulley SB
    JAMA; 2000 Apr; 283(14):1845-52. PubMed ID: 10770146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.
    Greenspan SL; Resnick NM; Parker RA
    JAMA; 2003 May; 289(19):2525-33. PubMed ID: 12759324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen plus progestin and risk of venous thrombosis.
    Cushman M; Kuller LH; Prentice R; Rodabough RJ; Psaty BM; Stafford RS; Sidney S; Rosendaal FR;
    JAMA; 2004 Oct; 292(13):1573-80. PubMed ID: 15467059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy comparison of Pueraria mirifica (PM) against conjugated equine estrogen (CEE) with/without medroxyprogesterone acetate (MPA) in the treatment of climacteric symptoms in perimenopausal women: phase III study.
    Chandeying V; Sangthawan M
    J Med Assoc Thai; 2007 Sep; 90(9):1720-6. PubMed ID: 17957910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC; Felson DT; Williams EN; Grady D
    Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy.
    Cumming DC
    Arch Intern Med; 1996 Oct; 156(19):2193-5. PubMed ID: 8885817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom experience after discontinuing use of estrogen plus progestin.
    Ockene JK; Barad DH; Cochrane BB; Larson JC; Gass M; Wassertheil-Smoller S; Manson JE; Barnabei VM; Lane DS; Brzyski RG; Rosal MC; Wylie-Rosett J; Hays J
    JAMA; 2005 Jul; 294(2):183-93. PubMed ID: 16014592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEPI in perspective. Good answers spawn pressing questions.
    Healy B
    JAMA; 1995 Jan; 273(3):240-1. PubMed ID: 7807665
    [No Abstract]   [Full Text] [Related]  

  • 17. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
    Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
    Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy.
    Nachtigall MJ; Smilen SW; Nachtigall RD; Nachtigall RH; Nachtigall LE
    Obstet Gynecol; 1992 Nov; 80(5):827-30. PubMed ID: 1328978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary cortisol and explicit memory in postmenopausal women using hormone replacement therapy.
    Hampson E; Duff-Canning SJ
    Psychoneuroendocrinology; 2016 Feb; 64():99-107. PubMed ID: 26630390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
    Herrington DM; Werbel BL; Riley WA; Pusser BE; Morgan TM
    J Am Coll Cardiol; 1999 Jun; 33(7):2030-7. PubMed ID: 10362210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.